Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Clinical Research Organizations-CROs -- Ignore unavailable to you. Want to Upgrade?

To: alexis s who wrote (5)	12/2/1999 8:42:00 PM
From: RWReeves	Read Replies (1) \| Respond to of 46

Well I can't say all CROs are equal but even within CRO's it can vary from office to office and from one Program Manager to another. Companies that know what they are doing of course, will try for the most solid trials possible. Trials can be poorly designed and/or poorly executed; either way you end up with a problem come review time. I would be very hesitant to impune one or the other of these companies, and I'd be a bit cautious of someone who does. Unless I hear it consistently about a CRO or a particular office/person, its just as possible the trial sponsor or one of the sites could be at fault in such isolated problem cases. RWR